Lung Cancer

Innovative technologies help you fight cancer and HPV.

Hope for a young man with lung cancer

Xiao Jian is a 25 years old young man from an ordinary family in Anhui province. In the summer of 2012, symptoms like coughing, fever, chest discomfort or breathing difficulties occasionally happened to him. Xiao Jiang thought they were caused by catching a cold until one day he was hard

Read More »

Why China being the prior destination for immunotherapy?

China has seen rapid growth in its biotech industry, particularly in the area of CAR T-cell therapy. Many Chinese biotech firms have developed their own CAR T-cell therapies and are actively seeking partnerships with international pharmaceutical companies. As the second-largest country in terms of the number of CAR T-cell therapy clinical trials, China’s research efforts reflect its commitment to advancing this innovative treatment approach.

Moreover, China has implemented various measures to make CAR T-cell therapy more accessible and affordable for patients. These patient-friendly pricing strategies have indeed contributed to making China an attractive destination for international patients for innovative therapies like CAR T-cell therapy. Comparatively, the cost of CAR T-cell therapy in China may be relatively more affordable than in other countries.

Effective and affordable immunotherapy and CAR T-cell Therapy?

Contact us and get detailed information about getting advanced immunotherapy and CAR T-cell therapy for the treatment of solid tumors, blood cancers and HPV infection.